Sarepta Therapeutics, Inc.
USD16.25
-1.36 (-7.72%)
CEO
Douglas S. Ingram
IPO Date
1997-06-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.60
Prev. Close
$17.61
Day Low
$15.95
Day High
$17.61
52W Low
$10.42
52W High
$43.92
Market Cap
$1.72B
Volume
3.66M
| 256 |
| $17.03 |
| 13 Mar 2026 | Rodino-Klapac Louise | President, R&D and Tech Ops | F-InKind | Disposed | 948 | $17.03 |
| 13 Mar 2026 | Mayo Stephen | director | S-Sale | Disposed | 7,239 | $17.02 |
| 13 Mar 2026 | Rothfuss Cristin | EVP, General Counsel | F-InKind | Disposed | 974 | $17.03 |
| 11 Mar 2026 | Wong Ryan Ho-Yan | Chief Financial Officer | F-InKind | Disposed | 162 | $16.95 |
| 11 Mar 2026 | Wong Ryan Ho-Yan | Chief Financial Officer | F-InKind | Disposed | 113 | $16.95 |
| 11 Mar 2026 | Rothfuss Cristin | EVP, General Counsel | F-InKind | Disposed | 484 | $16.95 |
| 11 Mar 2026 | Rothfuss Cristin | EVP, General Counsel | F-InKind | Disposed | 346 | $16.95 |
| 11 Mar 2026 | Rodino-Klapac Louise | President, R&D and Tech Ops | F-InKind | Disposed | 504 | $16.95 |
| $15,001 - $50,000 |
| 20 Apr 2023 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 17 Apr 2023 | Daniel Goldman | Daniel Goldman | Purchase | $15,001 - $50,000 |
| 24 Feb 2023 | Daniel Goldman | Daniel Goldman | Sale | $1,001 - $15,000 |
| 9 Dec 2020 | Josh Gottheimer | Josh Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 14 Oct 2020 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 17 Jul 2020 | Gilbert Cisneros | Gilbert Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 6 Jan 2020 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |